An antiviral nasal spray called Enovid that was developed in Canada and tested in the UK can reduce the viral loads in confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours, a press release said on Sunday.
According to the release, the Israeli-manufactured spray can be used up to five times a da. It’s suitable for children as young as 12 years old, and the Ministry of Health approved it in January this year. It will go on sale in the coming week.
Originally posted at vfinews.com